Insider Transactions Reported by 16 Insiders of Sigilon Therapeutics, Inc.

Location
Cambridge, MA

There are no Buy or Sell transactions made by insiders since 12 Mar 2025

Sigilon Therapeutics, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
May Orfali Chief Medical Officer $7,500 18 Feb 2022
Brooke Story Director $6,666 26 May 2022
Flagship Ventures Fund V General Partner LLC 10%+ Owner 11 Aug 2023
Coelho Rogerio Vivaldi PRESIDENT AND CEO, Director 11 Aug 2023
Kavita Patel Director 11 Aug 2023
Douglas G. Cole Director 11 Aug 2023
Matthew Paul Kowalsky Chief Of Staff And Clo 11 Aug 2023
John Cox Director 11 Aug 2023
DANIEL GRIFFITH ANDERSON Director 02 Jun 2021
Philip Ashton-Rickardt Chief Scientific Officer 11 Aug 2023
Josias Pontes Chief Financial Officer 11 Aug 2023
Qing Sarah Yuan Ctoo 11 Aug 2023
ELI LILLY & Co 10%+ Owner 11 Aug 2023
Stephen N. Oesterle Director 11 Aug 2023
Eric D. Shaff Director 11 Aug 2023
ROBERT R. RUFFOLO Director 11 Aug 2023

Recent Insider Transactions by Companies or Individuals for Sigilon Therapeutics, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
ELI LILLY & Co Common Stock Purchase 1,718,493 100 11 Aug 2023 Direct
Flagship Ventures Fund V General Partner LLC Common Stock Disposition pursuant to a tender of shares in a change of control transaction -100% -683,760 0 11 Aug 2023 By Flagship Ventures Fund V, L.P.
Flagship Ventures Fund V General Partner LLC Common Stock Disposition pursuant to a tender of shares in a change of control transaction -100% -113,960 0 11 Aug 2023 By Flagship Pioneering Special Opportunities Fund II, L.P.
Josias Pontes Common Stock Disposed to Issuer -100% -3,504 0 11 Aug 2023 Direct
Josias Pontes Stock Option (Right to Buy) Disposed to Issuer -100% -10,767 0 11 Aug 2023 Direct
Philip Ashton-Rickardt Stock Option (Right to Buy) Disposed to Issuer -100% -8,845 0 11 Aug 2023 Direct
Qing Sarah Yuan Common Stock Disposed to Issuer -100% -2,884 0 11 Aug 2023 Direct
Qing Sarah Yuan Stock Option (Right to Buy) Disposed to Issuer -100% -8,846 0 11 Aug 2023 Direct
Matthew Paul Kowalsky Common Stock Disposed to Issuer -100% -1,925 0 11 Aug 2023 Direct
Matthew Paul Kowalsky Stock Option (Right to Buy) Disposed to Issuer -100% -12,690 0 11 Aug 2023 Direct
Kavita Patel Stock Option (Right to Buy) Disposed to Issuer -100% -1,366 0 11 Aug 2023 Direct
Eric D. Shaff Stock Option (Right to Buy) Disposed to Issuer -100% -1,366 0 11 Aug 2023 Direct
Coelho Rogerio Vivaldi Common Stock Disposed to Issuer -100% -12,169 0 11 Aug 2023 Direct
Coelho Rogerio Vivaldi Stock Option (Right to Buy) Disposed to Issuer -100% -35,382 0 11 Aug 2023 Direct
John Cox Common Stock Disposed to Issuer -100% -341 0 11 Aug 2023 Direct
John Cox Stock Option (Right to Buy) Disposed to Issuer -100% -1,366 0 11 Aug 2023 Direct
Douglas G. Cole Stock Option (Right to Buy) Disposed to Issuer -100% -1,366 0 11 Aug 2023 Direct
ROBERT R. RUFFOLO Stock Option (Right to Buy) Disposed to Issuer -100% -5,120 0 11 Aug 2023 Direct
Stephen N. Oesterle Stock Option (Right to Buy) Disposed to Issuer -100% -5,639 0 11 Aug 2023 Direct
Qing Sarah Yuan Common Stock Options Exercise 2,884 2,884 27 Jul 2023 Direct
Qing Sarah Yuan Stock Option (Right to Buy) Options Exercise -31.2% -2,884 6,346 27 Jul 2023 Direct
Josias Pontes Common Stock Options Exercise 79.8% 1,444 3,254 21 Jul 2023 Direct
Josias Pontes Stock Option (Right to Buy) Options Exercise -31.3% -1,444 3,171 21 Jul 2023 Direct
Coelho Rogerio Vivaldi Common Stock Options Exercise 85.9% 5,528 11,963 21 Jul 2023 Direct
Coelho Rogerio Vivaldi Stock Option (Right to Buy) Options Exercise -31.2% -5,528 12,163 21 Jul 2023 Direct
Kavita Patel Stock Option (Right to Buy) Award 8,888 8,888 19 May 2023 Direct
Eric D. Shaff Stock Option (Right to Buy) Award 8,888 8,888 19 May 2023 Direct
John Cox Stock Option (Right to Buy) Award 8,888 8,888 19 May 2023 Direct
Douglas G. Cole Stock Option (Right to Buy) Award 8,888 8,888 19 May 2023 Direct
ROBERT R. RUFFOLO Stock Option (Right to Buy) Award 8,888 8,888 19 May 2023 Direct
Stephen N. Oesterle Stock Option (Right to Buy) Award 8,888 8,888 19 May 2023 Direct
Josias Pontes Stock Option (Right to Buy) Award 140,000 140,000 28 Feb 2023 Direct
Philip Ashton-Rickardt Stock Option (Right to Buy) Award 115,000 115,000 28 Feb 2023 Direct
Qing Sarah Yuan Stock Option (Right to Buy) Award 115,000 115,000 28 Feb 2023 Direct
Matthew Paul Kowalsky Stock Option (Right to Buy) Award 165,000 165,000 28 Feb 2023 Direct
Coelho Rogerio Vivaldi Stock Option (Right to Buy) Award 460,000 460,000 28 Feb 2023 Direct
Brooke Story Stock Option (Right to Buy) Award 8,888 8,888 26 May 2022 Direct
Kavita Patel Stock Option (Right to Buy) Award 8,888 8,888 26 May 2022 Direct
Eric D. Shaff Stock Option (Right to Buy) Award 8,888 8,888 26 May 2022 Direct
John Cox Stock Option (Right to Buy) Award 8,888 8,888 26 May 2022 Direct
Douglas G. Cole Stock Option (Right to Buy) Award 8,888 8,888 26 May 2022 Direct
ROBERT R. RUFFOLO Stock Option (Right to Buy) Award 8,888 8,888 26 May 2022 Direct
Stephen N. Oesterle Stock Option (Right to Buy) Award 8,888 8,888 26 May 2022 Direct
Qing Sarah Yuan Stock Option (Right to Buy) Award 120,000 120,000 01 Apr 2022 Direct
Philip Ashton-Rickardt Stock Option (Right to Buy) Award 90,000 90,000 18 Feb 2022 Direct
Josias Pontes Stock Option (Right to Buy) Award 60,000 60,000 18 Feb 2022 Direct
May Orfali Stock Option (Right to Buy) Award 10,000 10,000 18 Feb 2022 Direct
Coelho Rogerio Vivaldi Stock Option (Right to Buy) Award 230,000 230,000 18 Feb 2022 Direct
Josias Pontes Stock Option (Right to Buy) Award 65,000 65,000 03 Jan 2022 Direct
May Orfali Stock Option (Right to Buy) Award 10,000 10,000 03 Jan 2022 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.